(Q39262525)

10 September 2017

title

Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma (English)

1 reference

10 September 2017

5

1 reference

10 September 2017

B Greve

1

1 reference

10 September 2017

F Sheikh-Mounessi

2

1 reference

10 September 2017

B Kemper

3

1 reference

10 September 2017

I Ernst

4

1 reference

10 September 2017

H T Eich

6

1 reference

10 September 2017

publication date

10 October 2012

1 reference

Strahlentherapie und Onkologie

10 September 2017

published in

1 reference

10 September 2017

volume

188

1 reference

10 September 2017

issue

11

1 reference

10 September 2017

page(s)

1038-1047

1 reference

https://scigraph.springernature.com/pub.10.1007/s00066-012-0223-z

10 September 2017

exact match

0 references

cites work

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Use of radiation therapy for patients with soft-tissue and bone sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Targeting survivin in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin and apoptosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Radiation-induced survivin nuclear accumulation is linked to DNA damage repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin is a novel target of CD44-promoted breast tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Cancer cells survive with survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Protein expression following gamma-irradiation relevant to growth arrest and apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Cancer treatment: the combination of vaccination with other therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Cancer stem cells and microenvironment in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Parameter-optimized digital holographic microscope for high-resolution living-cell analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Investigation of living pancreas tumor cells by digital holographic microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Label-free quantitative cell division monitoring of endothelial cells by digital holographic microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

CellProfiler: image analysis software for identifying and quantifying cell phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

HBXIP functions as a cofactor of survivin in apoptosis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

The case for Survivin as mitotic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Survivin in solid tumors: rationale for development of inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

The clinical use of biomarkers as prognostic factors in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Curcumin Affects Components of the Chromosomal Passenger Complex and Induces Mitotic Catastrophe in Apoptosis-Resistant Bcr-Abl-Expressing Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0223-Z

Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer

21 January 2018

1 reference

12 December 2020

Isolation of synaptic terminals from Alzheimer's disease cortex

1 reference

12 December 2020

Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines

1 reference

12 December 2020

[Survivin in cancerology : molecular aspects and therapeutic applications]

1 reference

12 December 2020

Nuclear survivin expression predicts poorer prognosis in glioblastoma

1 reference

12 December 2020

Ewing sarcoma family of tumors

1 reference

12 December 2020

10.1007/S00066-012-0223-Z

Identifiers

DOI

1 reference

10 September 2017

1 reference